Novartis AGNVSNYSE
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+28.6%
5Y CAGR+5.8%
Year-over-Year Change
Income taxes paid or accrued
3Y CAGR
+28.6%/yr
vs -3.4%/yr prior
5Y CAGR
+5.8%/yr
Recent acceleration
Acceleration
+32.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.40B | +40.9% |
| 2024 | $1.70B | +208.7% |
| 2023 | $551.00M | -51.2% |
| 2022 | $1.13B | -30.6% |
| 2021 | $1.63B | -10.1% |
| 2020 | $1.81B | +0.8% |
| 2019 | $1.79B | +38.5% |
| 2018 | $1.29B | -19.2% |
| 2017 | $1.60B | +43.3% |
| 2016 | $1.12B | - |